FBT vs. BBC
FBT (First Trust Amex Biotechnology Index) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both Health & Biotech Equities funds - FBT tracks the NYSE Arca Biotechnology Index while BBC tracks the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 10 years, FBT returned 8.86%/yr vs 7.64%/yr for BBC. A 0.80 correlation means they provide meaningful diversification when combined. FBT charges 0.57%/yr vs 0.79%/yr for BBC.
Performance
FBT vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBT achieves a 7.08% return, which is significantly lower than BBC's 8.64% return. Over the past 10 years, FBT has outperformed BBC with an annualized return of 8.86%, while BBC has yielded a comparatively lower 7.64% annualized return.
FBT
- 1D
- 2.92%
- 1M
- 6.19%
- YTD
- 7.08%
- 6M
- 3.95%
- 1Y
- 35.94%
- 3Y*
- 12.40%
- 5Y*
- 6.79%
- 10Y*
- 8.86%
BBC
- 1D
- 0.43%
- 1M
- -6.52%
- YTD
- 8.64%
- 6M
- 14.08%
- 1Y
- 116.78%
- 3Y*
- 19.99%
- 5Y*
- -1.96%
- 10Y*
- 7.64%
FBT vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 7.08% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.64% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
Correlation
The correlation between FBT and BBC is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.64 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.68 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.75 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.78 |
Correlation (All Time) Calculated using the full available price history since Dec 18, 2014 | 0.80 |
The correlation between FBT and BBC shifts across timeframes, from 0.64 (1 year) to 0.80 (all time), reflecting how their relationship changes across market environments.
FBT vs. BBC - Sectors Allocation Comparison
Sectors
FBT
BBC
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBT
BBC
Basic Materials
FBT
-
BBC
-
Communication Services
FBT
-
BBC
-
Consumer Cyclical
FBT
-
BBC
-
Consumer Defensive
FBT
-
BBC
-
Energy
FBT
-
BBC
-
Financial Services
FBT
-
BBC
-
Industrials
FBT
-
BBC
-
Real Estate
FBT
-
BBC
-
Technology
FBT
-
BBC
-
Utilities
FBT
-
BBC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT vs. BBC — Risk / Return Rank
FBT
BBC
FBT vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.58 | ||
| Sortino ratioReturn per unit of downside risk | -1.42 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.46 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 2.53 | 7.78 | -5.25 |
| Martin ratioReturn relative to average drawdown | 7.43 | 24.80 | -17.37 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FBT | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.74 | 3.32 | -1.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | -0.05 | +0.36 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.20 | +0.17 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.12 | +0.39 |
Drawdowns
FBT vs. BBC - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for FBT and BBC.
Loading charts...
Drawdown Indicators
| FBT | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -76.85% | +36.34% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -15.10% | +0.84% |
Max Drawdown (3Y)Largest decline over 3 years | -20.05% | -54.45% | +34.40% |
Max Drawdown (5Y)Largest decline over 5 years | -29.05% | -72.44% | +43.39% |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | -76.85% | +44.48% |
Current DrawdownCurrent decline from peak | -0.72% | -30.27% | +29.55% |
Average DrawdownAverage peak-to-trough decline | -11.17% | -37.14% | +25.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.85% | 4.73% | +0.12% |
Volatility
FBT vs. BBC - Volatility Comparison
The current volatility for First Trust Amex Biotechnology Index (FBT) is 6.94%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.94% | 10.93% | -3.99% |
Volatility (6M)Calculated over the trailing 6-month period | 15.87% | 26.43% | -10.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.79% | 35.50% | -14.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.89% | 39.31% | -17.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.91% | 37.74% | -13.83% |
FBT vs. BBC - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
FBT vs. BBC - Dividend Comparison
FBT has not paid dividends to shareholders, while BBC's dividend yield for the trailing twelve months is around 1.56%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.56% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
Frequently Asked Questions
FBT and BBC have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.93%) compared to FBT (6.94%). In terms of maximum drawdown, FBT dropped -40.51% vs BBC's -76.85%.
On 10-year performance, FBT leads with 8.86% vs 7.64% for BBC. On fees, FBT is cheaper at 0.57% per year. On volatility, FBT has been the lower-risk option at 6.94%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FBT has performed better with a 8.86% return vs 7.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FBT is cheaper with a 0.57% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.56%, compared with 0.00% for FBT.
FBT tracks NYSE Arca Biotechnology Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: First Trust and Virtus Investment Partners. Their fees differ too: 0.57% for FBT and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (3.32 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FBT and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer